Huber J - Search Results

1

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.

Shaked Y, Bertolini F, Man S, Rogers MS, Cervi D, Foutz T, Rawn K, Voskas D, Dumont DJ, Ben-David Y, Lawler J, Henkin J, Huber J, Hicklin DJ, D'Amato RJ, Kerbel RS. Shaked Y, et al. Among authors: huber j. Cancer Cell. 2005 Jan;7(1):101-11. doi: 10.1016/j.ccr.2004.11.023. Cancer Cell. 2005. PMID: 15652753 Free article.

2

Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.

Bocci G, Man S, Green SK, Francia G, Ebos JM, du Manoir JM, Weinerman A, Emmenegger U, Ma L, Thorpe P, Davidoff A, Huber J, Hicklin DJ, Kerbel RS. Bocci G, et al. Among authors: huber j. Cancer Res. 2004 Sep 15;64(18):6616-25. doi: 10.1158/0008-5472.CAN-04-0401. Cancer Res. 2004. PMID: 15374976

3

Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts.

Izumi Y, di Tomaso E, Hooper A, Huang P, Huber J, Hicklin DJ, Fukumura D, Jain RK, Suit HD. Izumi Y, et al. Among authors: huber j. Cancer Res. 2003 Feb 15;63(4):747-51. Cancer Res. 2003. PMID: 12591719

4

Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.

Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ. Wu Y, et al. Among authors: huber j. Clin Cancer Res. 2006 Nov 1;12(21):6573-84. doi: 10.1158/1078-0432.CCR-06-0831. Clin Cancer Res. 2006. PMID: 17085673

5

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ. Prewett M, et al. Among authors: huber j. Cancer Res. 1999 Oct 15;59(20):5209-18. Cancer Res. 1999. PMID: 10537299

6

Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies.

Patel D, Bassi R, Hooper AT, Sun H, Huber J, Hicklin DJ, Kang X. Patel D, et al. Among authors: huber j. Anticancer Res. 2008 Sep-Oct;28(5A):2679-86. Anticancer Res. 2008. PMID: 19035294 Free article.

7

Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.

Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H. Yoshiji H, et al. Among authors: huber j. Hepatology. 2002 Apr;35(4):834-42. doi: 10.1053/jhep.2002.32541. Hepatology. 2002. PMID: 11915029

8

Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.

Loizos N, Xu Y, Huber J, Liu M, Lu D, Finnerty B, Rolser R, Malikzay A, Persaud A, Corcoran E, Deevi DS, Balderes P, Bassi R, Jimenez X, Joynes CJ, Mangalampalli VR, Steiner P, Tonra JR, Wu Y, Pereira DS, Zhu Z, Ludwig DL, Hicklin DJ, Bohlen P, Witte L, Kussie P. Loizos N, et al. Among authors: huber j. Mol Cancer Ther. 2005 Mar;4(3):369-79. doi: 10.1158/1535-7163.MCT-04-0114. Mol Cancer Ther. 2005. PMID: 15767546

9

KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.

Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H. Yoshiji H, et al. Among authors: huber j. Hepatology. 1999 Nov;30(5):1179-86. doi: 10.1002/hep.510300509. Hepatology. 1999. PMID: 10534339

10

The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model.

Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Yoshiji H, et al. Among authors: huber j. Hepatology. 2001 Apr;33(4):841-7. doi: 10.1053/jhep.2001.23312. Hepatology. 2001. PMID: 11283848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,039 results

Search Page